Vol. 120, No. 1 (Supplement) 2015
Supplement abstract

Lanthanide-doped CaF2 and SrF2 nanoparticles for biomedical applications: in vivo and in vitro experimental studies

Published 2015-09-30

Keywords

  • Lanthanide ions,
  • Nanoparticles,
  • Cell viability

How to Cite

Portioli, C., Pedroni, M., Benati, D., Dusi, S., Donini, M., Mariotti, R., Bonafede, R., Perbellini, L., Cerpelloni, M., Speghini, A., & Bentivoglio, M. (2015). Lanthanide-doped CaF2 and SrF2 nanoparticles for biomedical applications: in vivo and in vitro experimental studies. Italian Journal of Anatomy and Embryology, 120(1), 185. Retrieved from https://oajournals.fupress.net/index.php/ijae/article/view/4141

Abstract

Among the wide range of nanoparticles (NPs) studied for diagnostic and therapeutic applications lanthanide-doped nanosystems have raised special interest [1]. Their very small dimension (10 nm) and upconversion emission property have increased the range of their applications from contrast agent probes in bioimaging to drug delivery systems [2,3]. Here, the cytotoxicity of rare earth (Yb and Er)-doped CaF2 and SrF2 NPs has been investigated both in vitro and in vivo. In vitro studies have been conducted in a motoneuron cell line as model of neuronal interaction, and in a line of human dendritic cells which play a key role in the immune response. In the motoneuron cell line, a weak response was observed at early time points while the cell viability showed an increment, except for the highest concentration of lanthanide- doped NPs. The levels of cytokines released from human dendritic cells were low and dose-dependent. The NP biodistribution was investigated after a single peripheral administration in mice. Aggregates of NPs were shown, with different techniques, mostly in peripheral organs (spleen and liver) after one day. A limited penetration of both CaF2 and SrF2 NPs was seen in the brain parenchyma, associated with a mild astrocytic activation. Since the present in vitro findings indicate that lanthanide- doped NPs are safe, and the in vivo data show that they can enter the brain parenchyma crossing the blood-brain barrier, these NPs may represent promising tools for diagnostic and therapeutical applications.